Literature DB >> 30515733

Evaluating the associations between urinary excretion of magnesium and that of other components in calcium stone-forming patients.

Sanaz Tavasoli1, Maryam Taheri2, Fatemeh Taheri3, Abbas Basiri1, Fahimeh Bagheri Amiri1.   

Abstract

PURPOSE: Magnesium plays numerous vital roles in human's body. It is known as a protective factor in stone formation by binding to oxalate in the intestinal and urinary system, and decreasing its absorption and crystallization, respectively. Due to controversies about the association between the 24-h urine magnesium and other urine metabolites in different studies, this study was designed to find a clear answer to this question.
METHODS: In this retrospective cross-sectional study, data from 24-h urinalysis of the calcium stone-forming (CSF) patients were assessed. The correlation between 24-h urine (24-U) magnesium to creatinine ratio (Mg/Cr) with other 24-U metabolites to creatinine ratio was assessed, using Spearman correlation test. The association between 24-U magnesium and 24-U oxalate was also studied in a multivariate logistic regression model.
RESULTS: Among 965 patients, the level of Mg/Cr showed a direct association with all other 24-U metabolite to Cr ratio (p-value < 0.001 for all analyses). The result of multivariate regression analysis showed that the higher quartile of 24-U oxalate (> 47 mg/24 h) increased the odds of 24-U magnesium more than 75 mg/24 h (data median) (OR 1.89, 95% CI 1.14-3.13) comparing with the lower quartile of 24-U oxalate (≤ 26 mg/24 h).
CONCLUSIONS: In a routine dietary habit, since rich sources of magnesium contain a high amount of oxalate at the same time, it is not surprising that magnesium level in 24-h urinalysis showed a direct association with 24-h urine oxalate.

Entities:  

Keywords:  Association; Calcium stones; Magnesium; Oxalate; Urine metabolites

Mesh:

Substances:

Year:  2018        PMID: 30515733     DOI: 10.1007/s11255-018-2036-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  11 in total

1.  Determination of stone composition by noncontrast spiral computed tomography in the clinical setting.

Authors:  S Y Nakada; D G Hoff; S Attai; D Heisey; D Blankenbaker; M Pozniak
Journal:  Urology       Date:  2000-06       Impact factor: 2.649

Review 2.  Structural and catalytic chemistry of magnesium-dependent enzymes.

Authors:  J A Cowan
Journal:  Biometals       Date:  2002-09       Impact factor: 2.949

Review 3.  Magnesium chemistry and biochemistry.

Authors:  Michael E Maguire; James A Cowan
Journal:  Biometals       Date:  2002-09       Impact factor: 2.949

4.  Rethinking the role of urinary magnesium in calcium urolithiasis.

Authors:  B F Schwartz; J Bruce; S Leslie; M L Stoller
Journal:  J Endourol       Date:  2001-04       Impact factor: 2.942

Review 5.  Magnesium therapy for nephrolithiasis.

Authors:  L Massey
Journal:  Magnes Res       Date:  2005-06       Impact factor: 1.115

6.  Aspects on estimation of the risk of calcium oxalate crystallization in urine.

Authors:  H G Tiselius
Journal:  Urol Int       Date:  1991       Impact factor: 2.089

7.  High dietary magnesium intake decreases hyperoxaluria in patients with nephrolithiasis.

Authors:  Brian H Eisner; Sonali Sheth; Stephen P Dretler; Benjamin Herrick; Vernon M Pais
Journal:  Urology       Date:  2012-08-22       Impact factor: 2.649

8.  Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol.

Authors:  F L Levy; B Adams-Huet; C Y Pak
Journal:  Am J Med       Date:  1995-01       Impact factor: 4.965

9.  Dietary risk factors for hyperoxaluria in calcium oxalate stone formers.

Authors:  Roswitha Siener; Dagmar Ebert; Claudia Nicolay; Albrecht Hesse
Journal:  Kidney Int       Date:  2003-03       Impact factor: 10.612

10.  [LithoRisk: A software for calculating and visualising nephrolithiasis risk profiles].

Authors:  M Marangella; M Petrarulo; P G Daniele; S Sammartano
Journal:  G Ital Nefrol       Date:  2002 Nov-Dec
View more
  4 in total

1.  Association between hypomagnesemia and severity of primary hyperparathyroidism: a retrospective study.

Authors:  Ding Na; Guo Tao; Liu Shu-Ying; Wang Qin-Yi; Qu Xiao-Li; Li Yong-Fang; Ou Yang-Na; Sheng Zhi-Feng; Yang Yan-Yi
Journal:  BMC Endocr Disord       Date:  2021-08-20       Impact factor: 2.763

2.  Protective effect of bee pollen in acute kidney injury, proteinuria, and crystalluria induced by ethylene glycol ingestion in rats.

Authors:  Asmae Elghouizi; Noori Al-Waili; Nawal Elmenyiy; Salma Elfetri; Abderrazak Aboulghazi; Ahmed Al-Waili; Badiaa Lyoussi
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

3.  Effects of COVID-19 pandemics on urinary metabolites in kidney stone patients: our kidney stone prevention clinic experience.

Authors:  Sanaz Tavasoli; Nasrin Borumandnia; Abbas Basiri; Maryam Taheri
Journal:  Environ Health Prev Med       Date:  2021-12-02       Impact factor: 3.674

4.  Global Variations in the Mineral Content of Bottled Still and Sparkling Water and a Description of the Possible Impact on Nephrological and Urological Diseases.

Authors:  Simone J M Stoots; Guido M Kamphuis; Rob Geraghty; Liffert Vogt; Michaël M E L Henderickx; B M Zeeshan Hameed; Sufyan Ibrahim; Amelia Pietropaolo; Enakshee Jamnadass; Sahar M Aljumaiah; Saeed B Hamri; Eugenio Ventimiglia; Olivier Traxer; Vineet Gauhar; Etienne X Keller; Vincent De Coninck; Otas Durutovic; Nariman K Gadzhiev; Laurian B Dragos; Tarik Emre Sener; Nick Rukin; Michele Talso; Panagiotis Kallidonis; Esteban Emiliani; Ewa Bres-Niewada; Kymora B Scotland; Naeem Bhojani; Athanasios Vagionis; Angela Piccirilli; Bhaskar K Somani
Journal:  J Clin Med       Date:  2021-06-27       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.